Member News - TAGLaw

Coblentz's Paul Tauber Seals Chronix Biomedical's Agreement with Myriad Genetics

Paul Tauber, Chair of Coblentz, Patch, Duffy & Bass's (San Francisco, California, USA) Corporate/Business Group, served as lead counsel for Chronix Biomedical in solidifying an exclusive license agreement with Myriad Genetics to commercialize Chronix's early cancer detection technology. Chronix is extremely pleased with the closing of this significant deal, one that will ultimately progress Chronix's proprietary technology and tests.

Special thanks go out to TAGLaw member firm Mitchell Silberberg & Knupp (Los Angeles, California, USA) for providing the facilities for the key meeting during the transaction. Mr. Tauber noted that utilizing the MSK office was of absolute importance in finalizing this license agreement. Click here for more information.
< Back